Schedule 13D ownership disclosure
Arcus Biosciences Inc
Common Stock, par value $0.0001 · CUSIP: 03969F109
Event date: 2025-07-13
- Filing-level shares
- 31,424,760
- Percent of class
- 29.7%
- GILEAD SCIENCES, INC.Reported CIK 0000882095
Shares: 31,424,760 · Class: 29.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-25-000309
- Form type
- SCHEDULE 13D/A
- Filer
- Arcus Biosciences, Inc.
- CIK
- CIK 1724521
- Filed
- Jul 15, 2025
- Reporting period
- Jul 13, 2025
- Description
- Schedule 13D beneficial ownership